BioSpace News Archive

Only twice-daily LAMA /LABA in the United States with COPD exacerbation data included in its prescribing information

Reference is made to the stock exchange announcement on 18 October 2019 regarding the successful completion of Nordic Nanovector ASA’s private placement of new shares The Private Placement is divided into two tranches, as further explained in the stock exchange announcement on 18 October 2019.

Quotient Limited, a commercial-stage diagnostics company, announced that financial results for its fiscal second quarter ended September 30, 2019, will be released before market open on Monday, November 4, 2019.

Densitas Inc. announced that its FDA-cleared densitas® densityai™ breast density assessment software will be available on the Nuance® AI Marketplace, which provides access to over 70 percent of all radiologists across the largest network of connected healthcare facilities in the USA.

Medtronic plc announced that Sean Salmon, previously Senior Vice President and President, Coronary and Structural Heart within the Cardiac and Vascular Group of Medtronic, has been named Executive Vice President and Group President of Medtronic Diabetes.

Bruker Corporation announced it will report third quarter 2019 financial results on Thursday, October 31, 2019, after the market closes.

Planned Phase 2 Multi-Site Trial to Evaluate ALKS 4230 in Combination With Pembrolizumab in Patients With Advanced or Recurrent Head and Neck Squamous Cell Cancer

Proteostasis Therapeutics, Inc., a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis and other diseases caused by dysfunctional protein processing, announced that the Company will host a Cystic Fibrosis Summit.

SmartPharm Therapeutics, a preclinical-stage pharmaceutical company focused on developing next-generation, non-viral gene therapies for the treatment of rare diseases, announced the appointment of John T. Potts, MD, DSc, to its Board of Directors.

A large complex sigmoid polyp in a 62-year-old male patient was successfully removed in a 60-minute procedure without surgical intervention using DiLumen C2, a second-generation endoscopic dual balloon colon stabilization accessory that employs two 6mm working channels that accommodate several flexible therapeutic instruments designed to efficiently retract and dissect tissue.